Edgewell Personal Care Cash & Equivalents Growth & History (EPC)
Edgewell Personal Care's cash and equivalents was $225.7M for fiscal 2025.
View full Edgewell Personal Care company overviewEdgewell Personal Care annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $225.7M | $16.6M | +7.94% |
| 2024 | 2024-09-30 | $209.1M | −$7.3M | −3.37% |
| 2023 | 2023-09-30 | $216.4M | $27.7M | +14.68% |
| 2022 | 2022-09-30 | $188.7M | −$290.5M | −60.62% |
| 2021 | 2021-09-30 | $479.2M | $114.5M | +31.40% |
| 2020 | 2020-09-30 | $364.7M | $23.1M | +6.76% |
| 2019 | 2019-09-30 | $341.6M | $75.2M | +28.23% |
| 2018 | 2018-09-30 | $266.4M | −$236.5M | −47.03% |
| 2017 | 2017-09-30 | $502.9M | −$236.0M | −31.94% |
| 2016 | 2016-09-30 | $738.9M | $26.8M | +3.76% |
| 2015 | 2015-09-30 | $712.1M | −$416.9M | −36.93% |
| 2014 | 2014-09-30 | $1.13B | $130.7M | +13.09% |
| 2013 | 2013-09-30 | $998.3M | $279.8M | +38.94% |
| 2012 | 2012-09-30 | $718.5M | $247.3M | +52.48% |
| 2011 | 2011-09-30 | $471.2M | −$158.5M | −25.17% |
| 2010 | 2010-09-30 | $629.7M | $270.4M | +75.26% |
| 2009 | 2009-09-30 | $359.3M | $188.1M | +109.87% |
| 2008 | 2008-09-30 | $171.2M | — | — |
Edgewell Personal Care quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $397.1M | $197.5M | +98.95% |
| Q2 2026 | 2026-03-31 | $299.7M | $129.6M | +76.19% |
| Q1 2026 | 2025-12-31 | $223.3M | $47.8M | +27.24% |
| Q4 2025 | 2025-09-30 | $225.7M | $16.6M | +7.94% |
| Q3 2025 | 2025-06-30 | $199.6M | $3.5M | +1.78% |
| Q2 2025 | 2025-03-31 | $170.1M | −$26.1M | −13.30% |
| Q1 2025 | 2024-12-31 | $175.5M | −$38.7M | −18.07% |
| Q4 2024 | 2024-09-30 | $209.1M | −$7.3M | −3.37% |
| Q3 2024 | 2024-06-30 | $196.1M | −$11.3M | −5.45% |
| Q2 2024 | 2024-03-31 | $196.2M | $41.0M | +26.42% |
| Q1 2024 | 2023-12-31 | $214.2M | — | — |
| Q4 2023 | 2023-09-30 | $216.4M | $27.7M | +14.68% |
| Q3 2023 | 2023-06-30 | $207.4M | $25.8M | +14.21% |
| Q2 2023 | 2023-03-31 | $155.2M | −$32.9M | −17.49% |
| Q4 2022 | 2022-09-30 | $188.7M | −$290.5M | −60.62% |
| Q3 2022 | 2022-06-30 | $181.6M | −$255.9M | −58.49% |
| Q2 2022 | 2022-03-31 | $188.1M | −$94.0M | −33.32% |
| Q1 2022 | 2021-12-31 | $239.8M | −$41.0M | −14.60% |
| Q4 2021 | 2021-09-30 | $479.2M | $114.5M | +31.40% |
| Q3 2021 | 2021-06-30 | $437.5M | −$74.4M | −14.53% |
| Q2 2021 | 2021-03-31 | $282.1M | −$26.7M | −8.65% |
| Q1 2021 | 2020-12-31 | $280.8M | $29.0M | +11.52% |
| Q4 2020 | 2020-09-30 | $364.7M | $23.1M | +6.76% |
| Q3 2020 | 2020-06-30 | $511.9M | $232.9M | +83.48% |
| Q2 2020 | 2020-03-31 | $308.8M | $64.2M | +26.25% |
| Q1 2020 | 2019-12-31 | $251.8M | $11.9M | +4.96% |
| Q4 2019 | 2019-09-30 | $341.6M | $75.2M | +28.23% |
| Q3 2019 | 2019-06-30 | $279.0M | $60.5M | +27.69% |
| Q2 2019 | 2019-03-31 | $244.6M | $1.0M | +0.41% |
| Q1 2019 | 2018-12-31 | $239.9M | −$290.0M | −54.73% |
| Q4 2018 | 2018-09-30 | $266.4M | −$236.5M | −47.03% |
| Q3 2018 | 2018-06-30 | $218.5M | −$236.4M | −51.97% |
| Q2 2018 | 2018-03-31 | $243.6M | −$159.3M | −39.54% |
| Q1 2018 | 2017-12-31 | $529.9M | $111.4M | +26.62% |
| Q4 2017 | 2017-09-30 | $502.9M | −$236.0M | −31.94% |
| Q3 2017 | 2017-06-30 | $454.9M | −$236.6M | −34.22% |
| Q2 2017 | 2017-03-31 | $402.9M | −$257.6M | −39.00% |
| Q1 2017 | 2016-12-31 | $418.5M | −$275.7M | −39.71% |
| Q4 2016 | 2016-09-30 | $738.9M | $26.8M | +3.76% |
| Q3 2016 | 2016-06-30 | $691.5M | −$398.6M | −36.57% |
| Q2 2016 | 2016-03-31 | $660.5M | −$453.8M | −40.73% |
| Q1 2016 | 2015-12-31 | $694.2M | −$437.4M | −38.65% |
| Q4 2015 | 2015-09-30 | $712.1M | −$416.9M | −36.93% |
| Q3 2015 | 2015-06-30 | $1.09B | $1.4M | +0.13% |
| Q2 2015 | 2015-03-31 | $1.11B | $122.6M | +12.36% |
| Q1 2015 | 2014-12-31 | $1.13B | $250.1M | +28.37% |
| Q4 2014 | 2014-09-30 | $1.13B | $130.7M | +13.09% |
| Q3 2014 | 2014-06-30 | $1.09B | $139.9M | +14.74% |
| Q2 2014 | 2014-03-31 | $991.7M | $141.0M | +16.57% |
| Q1 2014 | 2013-12-31 | $881.5M | $94.4M | +11.99% |
| Q4 2013 | 2013-09-30 | $998.3M | $279.8M | +38.94% |
| Q3 2013 | 2013-06-30 | $948.8M | $316.7M | +50.10% |
| Q2 2013 | 2013-03-31 | $850.7M | $288.9M | +51.42% |
| Q1 2013 | 2012-12-31 | $787.1M | $310.2M | +65.05% |
| Q4 2012 | 2012-09-30 | $718.5M | $247.3M | +52.48% |
| Q3 2012 | 2012-06-30 | $632.1M | $124.8M | +24.60% |
| Q2 2012 | 2012-03-31 | $561.8M | $83.8M | +17.53% |
| Q1 2012 | 2011-12-31 | $476.9M | −$1.1M | −0.23% |
| Q4 2011 | 2011-09-30 | $471.2M | −$158.5M | −25.17% |
| Q3 2011 | 2011-06-30 | $507.3M | $18.5M | +3.78% |
| Q2 2011 | 2011-03-31 | $478.0M | — | — |
| Q1 2011 | 2010-12-31 | $478.0M | — | — |
| Q4 2010 | 2010-09-30 | $629.7M | $270.4M | +75.26% |
| Q3 2010 | 2010-06-30 | $488.8M | — | — |
| Q4 2009 | 2009-09-30 | $359.3M | — | — |
Edgewell Personal Care cash and equivalents trends
Over the last five fiscal years, Edgewell Personal Care's cash and equivalents decreased from $364.7M to $225.7M, a change of −$139.0M. The latest reported quarter, Q3 2026, shows $397.1M.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edgewell Personal Care source filings ↗